September 2019 Funding Opportunities and Announcements
Please contact the Office of Corporate and Foundation Relations at cfr@gwu.edu for questions or inquiry about any of these opportunities.

Questions about this "funding flash"? Contact us at cancercenter@gwu.edu. View previous issues here. Interested in subscribing to future updates? Click the button below:
Pfizer Global Medical Grants - Global Breast Cancer Research Grants
The intent of this RFP is to invite investigators to submit innovative proposals focused on hormone receptor positive metastatic breast cancer and metastatic breast cancer. In addition, incorporation of the following into the proposed study would be of interest: a correlative/biomarker component using paired biopsy samples, cfDNA assessment, predictive signatures beyond gBRCA mutation in advanced breast cancer, or PK/PD biomarkers to explore potential mechanisms of resistance/response or synergistic effect.
Deadline: October 15, 2019
Amount and Project Period: Varies ($5M available, 6-8 studies selected)
Eligibility : PI must have a medical or postdoctoral degree. Both early career and experienced investigators are encouraged to apply, and consideration will be given to all proposals meeting research criteria.
Reviewers: Undisclosed independent review panel
American Cancer Society - The Role of Health Policy and Health Insurance in Improving Access to and Performance of Cancer Prevention, Early Detection and Treatment Services
Research to be funded by this RFA should focus on the changes in national, state, and/or local policy and the response to these changes by the health care systems, insurers, payers, communities, practices, and patients. The foundation is keenly interested in supporting rapid learning research to study the effects of health policy changes on patients, providers, and health systems.
Deadline: October 15, 2019/April 1, 2020
Amount and Project Period: $200,000-$1M over 1-5 years
Eligibility : Independent investigators at all stages of their career are eligible to apply. The usual ACS restriction to investigators within the first six years of their initial independent research appointment for the Research Scholar grant applicants does not apply to this RFA.
Reviewers: Each application is assigned to one of 20 Peer Review Committees on the field of study. Committees include 12-25 members, mostly researchers and physicians, sometimes health professionals, and one or two stakeholders (laypeople with a personal interest in research).
American Cancer Society - Pilot and Exploratory Projects in Palliative Cancer Patients and their Families
In an effort to support clinician investigators conducting patient-oriented research in palliative care, the American Cancer Society, in parallel with the National Palliative Care Research Center, is soliciting applications for pilot/exploratory research grants in palliative care for cancer patients and their families. These grants will generate the pilot data necessary to maximize an investigator's chances of successfully competing for larger grants.
Deadline: October 15, 2019/April 1, 2020
Amount and Project Period: $120,000 over 1-2 years
Eligibility : Applicants must hold a doctorate degree (MD, PhD or equivalent) and have a full-time faculty position or equivalent at a college, university, medical school, or other fiscally responsible not-for-profit organization within the United States. Independent investigators at all stages of their career are eligible to apply. Thus, the usual ACS restriction to investigators within the first six years of their initial independent research appointment does not apply to this request for applications (RFA).
Reviewers: Each application is assigned to one of 20 Peer Review Committees on the field of study. Committees include 12-25 members, mostly researchers and physicians, sometimes health professionals, and one or two stakeholders (laypeople with a personal interest in research).
Pfizer - Biosimilars Research in Solid Tumors
Pfizer announces an investigator sponsored research grant program seeking competitive proposals for interventional, non-interventional, basic science, or other studies on biosimilars research in solid tumors.
Deadline: October 15, 2019
Amount and Project Period: Varies ($500,000 budgeted for 4-6 studies)
Eligibility : PI must have a medical or postdoctoral degree (MD, PhD or equivalent), an advanced nursing degree (BSN with MS/PhD), or a degree in pharmacy, physiotherapy or social work.
Reviewers: Internal Pfizer review process
Pfizer - Biosimilars Education in Solid Tumors
The goal of this RFP is to support the prudent (safe and effective) use of biosimilar drugs in the treatment of solid tumors, in particular colorectal cancer and HER2+ breast cancer.
Deadline: October 16, 2019
Amount and Project Period: $250,000 over 1-2 years
Eligibility : The following may apply: Medical, nursing, allied health and/or pharmacy professional schools; health care institutions (both large and small); professional associations and medical societies; patient education or patient advocacy associations; medical education companies; and other entities with a mission related to health care professional education and/or health care improvement.
Reviewers: Internal Pfizer review process
Pfizer - PARP-Inhibitors in Prostate Cancer
Projects that will be considered for Pfizer support will focus on increasing the understanding of PARP inhibitors and the future of their use in the treatment of advanced prostate cancer. Topics of interest include mechanisms of action of PARP inhibitors, selection of appropriate patients, biomarker testing process, analytical platforms and result interpretation to inform decision-making and management of patients treated with PARP inhibitors.
Deadline: October 30, 2019
Amount and Project Period: $150,000 for up to 2 years
Eligibility : The following may apply: Medical, nursing, allied health, and/or pharmacy professional schools; health care institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to health care professional education and/or health care improvement.
Reviewers: Internal Pfizer review process
Chordoma Foundation - Cancer Research Institute Chordoma-Focused Immunology Grants
The Cancer Research Institute (CRI) and Chordoma Foundation have established a research partnership to jointly fund chordoma-focused immunology grants awarded under CRI's Clinic and Laboratory Integration Program (CLIP). CLIP grants provide catalytic support for translational research to explore clinically relevant immunotherapy-related questions. The goal for this special call-out for chordoma proposals is to support pre-clinical and translational research aimed to study important topics at the intersection of laboratory and clinical research in order to optimize and advance cancer immunotherapies for chordoma patients.
Deadline: November 1, 2019 (LOI)
Amount and Project Period: $200,000 over 2 years
Eligibility : Candidates for a CLIP grant must hold a faculty appointment as a tenure-track assistant professor (or higher rank) at the time of award activation.
Reviewers: Undisclosed
Pfizer - Treatment Patterns of CDK 4/6 Inhibitor Utilization in HR+/HER2- Metastatic Breast Cancer
The intent of this QI RFP is to support cancer care facilities interested in identifying and reducing unwarranted variations and/or disparities in care by (1) exploring utilization patterns of CDK 4/6 inhibitors for the treatment of HR+/HER2- metastatic breast cancer, and (2) implementing process improvement intervention(s) to address identified issues.
Deadline: November 4, 2019
Amount and Project Period: $100,000 for up to 1.5 years
Eligibility : Cancer care facilities including community cancer centers, hospitals, health systems, comprehensive cancer centers, and networks of oncology clinics. Individual physician-owned practices are not eligible.
Reviewers: Internal Pfizer review process
American Gastroenterological Association - AGA-Gastric Cancer Foundation Ben Feinstein Memorial Research Scholar Award in Gastric Cancer
The objective of this award is to support young gastroenterologists working toward independent and productive research careers in digestive diseases by ensuring that a major proportion of their time is protected for research (i.e. a minimum of 75% effort dedicated to the proposed project). The award will support young faculty (not fellows) who have demonstrated exceptional promise and have some record of accomplishment in research in upper GI (gastric) cancer. Proposals can be of a translational or clinical nature.
Deadline: November 13, 2019
Amount and Project Period: $300,000 over 1 year
Eligibility : Candidates for this award must hold an MD, PhD or equivalent degree (e.g. MB, ChB, MBBS, DO) and a full-time faculty position at a North American institution by the start date of this award. Candidates must be within seven years of completing their terminal degree or completion of clinical training. Candidates must be AGA members in good standing.
Reviewers: Scientific merit will be reviewed by a panel comprising members of the AGA Institute Research Awards Panel. The AGA Institute Research Scholar Award Oversight Council will finalize selection of award recipients.
Pancreatic Cancer Action Network Translational Research Grant
Supports an independent investigator conducting high priority pancreatic cancer research that is poised for important translational next steps to help move scientific discovery to application in patients. Proposed research should aim to identify novel targets and approaches to the treatment of pancreatic cancer or understand and circumvent treatment resistance.
Deadline: December 6, 2019
Amount and Project Period: $500,000 over 2 years
Eligibility : Applicants must have a doctoral degree in the biomedical sciences or a field applicable to health science research and not currently be a candidate for a further doctoral degree. PI must be affiliated with an accredited academic, medical or research institution.
Reviewers: Scientific review committee composed of scientists from academia and industry who are respected for their accomplishments in pancreatic cancer, translational research and clinical trials. A pancreatic cancer research advocate will also serve on the committee to represent the collective patient perspective.
Pancreatic Cancer Action Network Career Development Award
Supports junior faculty to conduct pancreatic cancer research and establish successful career paths in the field. Proposed research may be basic, translational, clinical or epidemiological in nature and must have direct applicability and relevance to pancreatic cancer.
Deadline: December 13, 2019
Amount and Project Period: $200,000 over 2 years
Eligibility : Applicants must have a doctoral degree in the biomedical sciences or in a field applicable to health science research and may not currently be a candidate for a further doctoral degree. Applicants must hold a faculty position with the title of assistant professor, instructor, research assistant professor or equivalent. Applicants must have completed their most recent doctoral degree within the past 11 years and must have independent laboratory space. Applicants may not have currently or previously served as PI on major research awards or grants (NIH RO1 or equivalent totaling $500,000 or more).
 Reviewers: Scientific review committee appointed by funder's Research Grants Department. Committee is composed of scientists that are respected for their accomplishments in pancreatic cancer research and viewed as leaders in the field.
The Elsa U. Pardee Foundation Cancer Research Program
The Elsa U. Pardee Foundation funds research directed toward identifying new treatments or cures for cancer. The foundation funds projects for a one year period which will allow establishment of capabilities of new cancer researchers, or new cancer approaches by established cancer researchers. It is anticipated that this early stage funding by the foundation may lead to subsequent and expanded support using government agency funding. Project relevance to cancer detection, treatment or cure should be clearly identified.
Deadline: December 31, 2019
Amount and Project Period: Historically around $150,000 over 1 year
Eligibility : New cancer researchers, or new cancer approaches by established cancer researchers.
Reviewers: Grant proposals are reviewed and awarded by their committee of distinguished medical professionals